CuraSen
Operator of a biopharmaceutical company intended for the development of novel treatments for neurodegenerative diseases. The company engages in developing small molecules that target innate homeostati...
Valuation
$0
Share Price
N/A
Total Raised
$95.9M
Last Round
N/A